BMJ 343:d4013. 29. Zornosa C, Mamet R, Reid ME, Ettinger DS, Otterson GA, Rabin MS, Hayman J, Niland JC, Pisters K, Committee NOODN-SCLCD-SE: Utilization of adjuvant therapy among completely resected non-small cell lung cancer (NSCLC) patients in the National Comprehensive Cancer Network (NCCN) Outcomes Database Project. ASCO Meeting Abstracts 28:7017. 30. Miksad RA, Gonen M, Lynch TJ, Roberts TG Jr: Interpreting trial Fer-1 datasheet results in light of conflicting evidence: a Bayesian analysis of adjuvant chemotherapy for non-small-cell lung cancer. J Clin Oncol 2009, 27:2245–2252.PubMedCrossRef
31. Strauss GM, Wang XF, Maddaus M, Johnstone D, Johnson E, Harpole D, Gillenwater HH, Gu L, Sugarbaker find more D, Green MR, et al.: Adjuvant chemotherapy
(AC) in stage IB non-small cell lung cancer (NSCLC): Long-term follow-up of Cancer and Leukemia Group B (CALGB) 9633. ASCO Meeting Abstracts 29:7015. 32. Kato H, Ichinose Y, Ohta M, Hata E, Tsubota N, Tada H, Watanabe Y, Wada H, Tsuboi M, Hamajima N: A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 2004, 350:1713–1721.PubMedCrossRef 33. Wakelee H, Dubey S, Gandara D: Optimal adjuvant therapy for non-small cell lung cancer–how to handle stage I disease. Oncologist 2007, 12:331–337.PubMedCrossRef 34. Rami-Porta R, Ball D, Crowley J, Giroux DJ, Jett J, Travis WD, Tsuboi M, Vallieres E, Goldstraw P: The IASLC Lung Cancer Staging
Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007, 2:593–602.PubMedCrossRef 35. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V, Sobin L: The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007, 2:706–714.PubMedCrossRef 36. Ruffini E, Asioli S, Filosso PL, Edoxaban Buffoni L, Bruna MC, Mossetti C, Solidoro P, Oliaro A: Significance of the Verubecestat in vitro presence of microscopic vascular invasion after complete resection of Stage I-II pT1-T2N0 non-small cell lung cancer and its relation with T-Size categories: did the 2009 7th edition of the TNM staging system miss something? J Thorac Oncol 6:319–326. 37. Maeda R, Yoshida J, Ishii G, Hishida T, Nishimura M, Nagai K: Poor prognostic factors in patients with stage IB non-small cell lung cancer according to the seventh edition TNM classification. Chest 139:855–861. 38. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group Lancet 1998, 352:257–263. 39. Postoperative radiotherapy for non-small cell lung cancer Cochrane Database Syst Rev 2005, CD002142. 40.